Tehseen Salimi

Tehseen Salimi has had a diverse and extensive work experience in the pharmaceutical and healthcare industry. Their most recent role was as the VP of Medical Affairs and Real-world Evidence at Taiho Oncology, Inc., where they were responsible for developing the Medical Affairs strategy across the company's portfolio. Prior to that, they were the Vice President of Medical Affairs and Real-world Evidence at G1 Therapeutics, Inc., where they built and led medical affairs functions and teams for the oncology and immunology portfolio.

Tehseen has also held leadership positions at Merck, Trevena ,Inc, AstraZeneca, sanofi-aventis, Sanofi, HOFFMAN LA ROCHE, and CIGNA. Throughout their career, they have demonstrated expertise in areas such as medical strategy development, real-world evidence generation, medical communication, and team leadership. Tehseen has a track record of successfully establishing and leading various sub-functional teams, developing integrated medical affairs strategies, and executing evidence generation and medical communication plans. Overall, Tehseen Salimi has a proven ability to drive success in medical affairs and bring value to healthcare organizations.

Tehseen Salimi completed a Preventive Medicine Fellowship Program at the University of Massachusetts Medical Center in Worcester, MA from 1995 to 1996. Prior to that, they obtained a Masters of Health Administration (MHA) from Clark University Graduate School of Management and the University of Massachusetts Medical School, with the year of completion unspecified. They also hold a Medical Doctor (MD) degree from Nawabshah Medical College at the University of Sind in Pakistan, completed in 1983.